Chronic kidney disease （CKD） has become a worldwide health and social problem. Retarding its progression to end-stage renal disease is beneficial both to the patients and the healthcare system. Plenty of clinical tr...Chronic kidney disease （CKD） has become a worldwide health and social problem. Retarding its progression to end-stage renal disease is beneficial both to the patients and the healthcare system. Plenty of clinical trials have indicated that enema with Chinese medicine could effectively prevent chronic renal failure, and was widely used in the clinical practice. However, studies on mechanism were still nearly blank, which may prevent further improvement of therapeutic efficacy. Recent studies had discovered that colon was an important organ where uremic toxins were generated. The uremic toxins involved could not only promote CKD progression, but also was closely correlated with CKD mortality. Reducing production and promoting excretion of toxins were confirmed to reduce renal tubule interstitial fibrosis and delay renal progression. On the basis of the theory of gut-kidney axis above, we had conducted pilot clinical researches to evaluate the effect of enema with Chinese medicine on the intestinal flora, gut barrier, enterogenous uremic toxins and renal protection. The preliminary results revealed that rheum enema through colon could accelerate intestinal dynamics, improve intestinal barrier function, regulate intestinal flora and reduce production and absorption of intestine-derived uremic toxins such as indoxyl sulfate, which may reduce renal fibrosis and delay renal progression. Further studies could provide more evidence for colon as a new therapeutic target for the treatment of CKD with Chinese medicine.展开更多
目的：探讨IgA肾病患者的临床表现与病理特征之间的相关性。方法对陕西省中医院肾病科2008年1月至2012年12月间确诊为原发性 IgA肾病的300例患者的临床病理资料进行研究分析。结果①中青年组发病比例最高（90%）；各年龄段均以血尿、蛋...目的：探讨IgA肾病患者的临床表现与病理特征之间的相关性。方法对陕西省中医院肾病科2008年1月至2012年12月间确诊为原发性 IgA肾病的300例患者的临床病理资料进行研究分析。结果①中青年组发病比例最高（90%）；各年龄段均以血尿、蛋白尿为主要临床表现。高血压、肾功异常在≥60岁组发生率最高,分别为29.3%和28%。②免疫荧光IgA＋IgM病理类型所占比例最高（36%）,其次为单纯性IgA（29.7%）、IgA＋IgM＋IgG（17.7%）、IgA＋IgG（16.7%）。Ⅰ~Ⅲ级分型中免疫荧光单纯 IgA所占比例最高；在 IV 和Ⅴ级中以 IgA＋IgM沉积所占比例最高,分别为45.5%、81.8%。所有 IgA 肾病中表现为 C3沉积的比例较高,为63.3%。③肾组织病理改变分级以Lee分级Ⅰ~Ⅳ为主,占96.3%。Ⅰ~Ⅴ级病理改变的临床表现均以血尿、蛋白尿为主,相比其他临床表现更多见（P＜0.05）,各病理分级中血尿、蛋白尿、血尿合并蛋白尿、高血压发生率无显著性差异,而肾功能异常的比例以Ⅴ级为著,其差异具有统计学意义（P＜0.05）。④Ⅰ~Ⅴ级病理改变中尿 RBC、尿蛋白异常所占比例无显著差异；病理类型Ⅳ级血清中C3下降最显著（P＜0.05）；病理类型Ⅴ级病例血清中 IgA 升高的比例最低,其差异具有统计学意义（P＜0.05）。而血清中肌酐异常的比例随着病理类型分级的升高,呈逐渐上升趋势,以病理类型Ⅴ级血清肌酐异常的比例最高。结论 IgA肾病具有临床表现、病理改变多样化等特点,IgA 肾病血尿、蛋白尿和高血压的发生率与病理分级无相关性,但随着病理分级的升高,肾功能异常的发生率增高。展开更多
文摘随着经济发展,人民生活方式和饮食结构发生改变,慢性肾脏病(chronic kidney disease,CKD)的患病率逐年提高,全球人群患病率已高达14.3%,我国18岁以上人群CKD患病率约为10.8%。在过去的20年间,全球CKD相关的死亡数量上升82.3%[1]。尤其是CKD 4期和5期的2年生存率仅为62%,年均死亡率超过20%,是普通人群的10倍[2]。全国血液透析病例登记系统(Chinese National Renal Data System,CNRDS)显示,我国血液透析患者数量庞大,截止2018年12月,在透患者已达57.9万例[3,4]。CKD为社会、家庭及个人带来沉重的经济负担,已成为世界各国所面临的重要公共卫生问题。大量的临床研究已初步证实中医药疗法在延缓CKD 3~5期进展方面有着一定的疗效和优势。
基金Supported by National Natural Science Foundation of China (No.81202819)the 2011 Construction Project from Research Studio of Famous Old Traditional Chinese Medicine Practitioners Experience Heritage,State Administration of Traditional Chinese Medicine(No.2012KT1301)
文摘Chronic kidney disease （CKD） has become a worldwide health and social problem. Retarding its progression to end-stage renal disease is beneficial both to the patients and the healthcare system. Plenty of clinical trials have indicated that enema with Chinese medicine could effectively prevent chronic renal failure, and was widely used in the clinical practice. However, studies on mechanism were still nearly blank, which may prevent further improvement of therapeutic efficacy. Recent studies had discovered that colon was an important organ where uremic toxins were generated. The uremic toxins involved could not only promote CKD progression, but also was closely correlated with CKD mortality. Reducing production and promoting excretion of toxins were confirmed to reduce renal tubule interstitial fibrosis and delay renal progression. On the basis of the theory of gut-kidney axis above, we had conducted pilot clinical researches to evaluate the effect of enema with Chinese medicine on the intestinal flora, gut barrier, enterogenous uremic toxins and renal protection. The preliminary results revealed that rheum enema through colon could accelerate intestinal dynamics, improve intestinal barrier function, regulate intestinal flora and reduce production and absorption of intestine-derived uremic toxins such as indoxyl sulfate, which may reduce renal fibrosis and delay renal progression. Further studies could provide more evidence for colon as a new therapeutic target for the treatment of CKD with Chinese medicine.
文摘目的：探讨IgA肾病患者的临床表现与病理特征之间的相关性。方法对陕西省中医院肾病科2008年1月至2012年12月间确诊为原发性 IgA肾病的300例患者的临床病理资料进行研究分析。结果①中青年组发病比例最高（90%）；各年龄段均以血尿、蛋白尿为主要临床表现。高血压、肾功异常在≥60岁组发生率最高,分别为29.3%和28%。②免疫荧光IgA＋IgM病理类型所占比例最高（36%）,其次为单纯性IgA（29.7%）、IgA＋IgM＋IgG（17.7%）、IgA＋IgG（16.7%）。Ⅰ~Ⅲ级分型中免疫荧光单纯 IgA所占比例最高；在 IV 和Ⅴ级中以 IgA＋IgM沉积所占比例最高,分别为45.5%、81.8%。所有 IgA 肾病中表现为 C3沉积的比例较高,为63.3%。③肾组织病理改变分级以Lee分级Ⅰ~Ⅳ为主,占96.3%。Ⅰ~Ⅴ级病理改变的临床表现均以血尿、蛋白尿为主,相比其他临床表现更多见（P＜0.05）,各病理分级中血尿、蛋白尿、血尿合并蛋白尿、高血压发生率无显著性差异,而肾功能异常的比例以Ⅴ级为著,其差异具有统计学意义（P＜0.05）。④Ⅰ~Ⅴ级病理改变中尿 RBC、尿蛋白异常所占比例无显著差异；病理类型Ⅳ级血清中C3下降最显著（P＜0.05）；病理类型Ⅴ级病例血清中 IgA 升高的比例最低,其差异具有统计学意义（P＜0.05）。而血清中肌酐异常的比例随着病理类型分级的升高,呈逐渐上升趋势,以病理类型Ⅴ级血清肌酐异常的比例最高。结论 IgA肾病具有临床表现、病理改变多样化等特点,IgA 肾病血尿、蛋白尿和高血压的发生率与病理分级无相关性,但随着病理分级的升高,肾功能异常的发生率增高。
